|
Sessile Serrated Adenoma/Polyp
|
0.100 |
Biomarker
|
disease |
BEFREE |
They all exhibited antibody against the nucleoprotein antigen SSA (Ro), as well as cutaneous involvement, features that have been previously associated with complement deficiency states.
|
3265961 |
1988 |
|
Sessile Serrated Adenoma/Polyp
|
0.100 |
Biomarker
|
disease |
BEFREE |
Finally, in the control group anti-SSA (Ro) antibodies were not present.
|
3498034 |
1987 |
|
Sessile Serrated Adenoma/Polyp
|
0.100 |
Biomarker
|
disease |
BEFREE |
The patients exhibit typical skin manifestations suggestive of SLE and DLE and often exhibit antibodies to SSA (Ro).
|
3892188 |
1985 |
|
Sessile Serrated Adenoma/Polyp
|
0.100 |
Biomarker
|
disease |
BEFREE |
A BRAF mutation was present in 82% of serrated carcinomas (SCas), 62% of serrated adenomas (SAs), 83% of serrated polyps with abnormal proliferation (SPAPs-syn. sessile serrated adenoma [SSA]), 76% of microvesicular serrated polyps (MVSPs), and was not found in any of the histologic categories of the traditional adenoma-carcinoma sequence.
|
17122504 |
2006 |
|
Sessile Serrated Adenoma/Polyp
|
0.100 |
Biomarker
|
disease |
BEFREE |
Abundant recent data suggest that sessile serrated adenoma/polyp (SSA/P) is an early precursor lesion in the serrated pathway of carcinogenesis.
|
21836485 |
2011 |
|
Sessile Serrated Adenoma/Polyp
|
0.100 |
Biomarker
|
disease |
BEFREE |
Most of the polyps (83%) were serrated polyps: microvesicular hyperplastic polyps (HP) (n=156), goblet cell HP (n=25), sessile serrated adenoma/polyps (SSA/P) (n=110), SSA/P with cytologic dysplasia (n=28), and traditional serrated adenomas (n=18).
|
22510757 |
2012 |
|
Sessile Serrated Adenoma/Polyp
|
0.100 |
Biomarker
|
disease |
BEFREE |
Although much data have accumulated on sessile serrated adenoma/polyp/lesion (SSA/P/L) in general, its characteristics in specified contexts are less well elucidated.
|
22782936 |
2012 |
|
Sessile Serrated Adenoma/Polyp
|
0.100 |
Biomarker
|
disease |
BEFREE |
In this study, we describe a previously undescribed pedunculated serrated polyp of the colon showing typical features of sessile serrated adenoma/polyp (SSA/P).
|
23648458 |
2013 |
|
Sessile Serrated Adenoma/Polyp
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Nondysplastic hyperplastic polyp (HP) or sessile serrated adenoma/polyp (SSA/P) precursor lesions were found in 56 (52.3%) TSAs, among which 32 (57.1%) cases showed a flat-elevated lesion with a type II pit pattern during endoscopy.
|
24225759 |
2013 |
|
Sessile Serrated Adenoma/Polyp
|
0.100 |
Biomarker
|
disease |
BEFREE |
The study group of appendiceal serrated lesions (n = 46) was divided into a non-dysplastic group (28/46, subclassified as 7 hyperplastic polyps and 21 sessile serrated adenoma/polyps (SSA/P) using colorectal diagnostic terminology) and dysplastic group (18/46, subclassified as 9 SSA/Ps with cytological dysplasia, 7 traditional serrated adenomas, and 2 adenomas with prominent serrations).
|
24439221 |
2014 |
|
Sessile Serrated Adenoma/Polyp
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Sessile serrated adenoma/polyp (SSA/P) is considered as an early precursor in the serrated neoplasia pathway leading to colorectal cancer development.
|
24925057 |
2015 |
|
Sessile Serrated Adenoma/Polyp
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Although a hyperplastic polyp (HP) shares morphological and molecular features with a sessile serrated adenoma/polyp (SSA/P), HPs and SSA/Ps are considered nonneoplastic and neoplastic epithelial polyps, respectively.
|
24935059 |
2014 |
|
Sessile Serrated Adenoma/Polyp
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Then we summarize the clinicopathological features, classification and molecular profiles of the two main precursor lesions that anchor the respective pathways: (i) sessile serrated adenoma/polyp (SSA/P), also called sessile serrated lesion (SSL), and (ii) traditional serrated adenoma (TSA).
|
25263173 |
2015 |
|
Sessile Serrated Adenoma/Polyp
|
0.100 |
Biomarker
|
disease |
BEFREE |
We performed genetic analysis and genome-wide DNA methylation analysis in aberrant crypt foci (ACF), SSA/P, and cancer in SSA/P specimens to show a close association between ACF and the SSA/P-cancer sequence.
|
25314065 |
2015 |
|
Sessile Serrated Adenoma/Polyp
|
0.100 |
Biomarker
|
disease |
BEFREE |
To clarify molecular alterations in serrated pathway of colorectal cancer (CRC), we performed epigenetic and genetic analyses in sessile serrated adenoma/polyps (SSA/P), traditional serrated adenomas (TSAs) and high-methylation CRC.
|
26510091 |
2016 |
|
Sessile Serrated Adenoma/Polyp
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
We aimed to compare the gut microbiome between tubular adenoma (TA) and sessile serrated adenoma/polyp (SSA/P).
|
27125587 |
2016 |
|
Sessile Serrated Adenoma/Polyp
|
0.100 |
Biomarker
|
disease |
BEFREE |
Accordingly, serrated polyps such as traditional serrated adenoma and sessile serrated adenoma/polyps (SSA/P) are now considered to be precursor lesions of the serrated pathway.
|
27376251 |
2017 |
|
Sessile Serrated Adenoma/Polyp
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Sessile serrated adenoma/polyp (SSA/P) is a colorectal polyp that has malignant potential.
|
27663716 |
2017 |
|
Sessile Serrated Adenoma/Polyp
|
0.100 |
Biomarker
|
disease |
BEFREE |
Sessile serrated adenoma/polyps (SSA/P) are premalignant lesions of colorectal cancer that are difficult to distinguish histologically from hyperplastic polyps (HP) of minimal to no malignant potential.
|
27705923 |
2017 |
|
Sessile Serrated Adenoma/Polyp
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Histopathological diagnoses of the LSTs were as follows: tubular adenoma, 12 cases (57%); sessile serrated adenoma/polyp (SSA/P), 4 cases (19%); Tis carcinoma, 1 case (5%); and T1 carcinoma, 4 cases (19 LSTs were found in the following locations: cecum, 1 case (5%); ascending colon, 6 cases (29%); transverse colon, 6 cases, (29%); descending colon, 1 case (5%); sigmoid colon, 3 cases (13%); and rectum, 4 cases (19%).
|
28052292 |
2017 |
|
Sessile Serrated Adenoma/Polyp
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
By using colonoscopies in adults aged ≥50 years (4/09-12/14), we stratified endoscopists by high and low ADRs (<15%, 15%-<25%, 25%-<35%, ≥35%) to determine corresponding SDRs by using 2 SDR measures, for screening and surveillance colonoscopies separately: (1) Clinically significant SDR (CSSDR), meaning colonoscopies with any sessile serrated adenoma/polyp (SSA/P), traditional serrated adenoma (TSA), or hyperplastic polyp (HP) >1 cm anywhere in the colon or HP >5 mm in the proximal colon only divided by the total number of screening and surveillance colonoscopies, respectively.
|
28153571 |
2017 |
|
Sessile Serrated Adenoma/Polyp
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The sessile serrated adenoma/polyp (SSA/P) is the most prevalent pre-invasive serrated lesion.
|
28257124 |
2017 |
|
Sessile Serrated Adenoma/Polyp
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Detection of flat adenoma, sessile serrated adenoma/polyp (SSA/P), and number of right-sided adenomas per patient were also assessed.
|
28365356 |
2017 |
|
Sessile Serrated Adenoma/Polyp
|
0.100 |
Biomarker
|
disease |
BEFREE |
Anti-SSA (Ro60) antibodies were found in two patients and anti-Ro52 antibodies were detectable in one patient.
|
28480635 |
2017 |
|
Sessile Serrated Adenoma/Polyp
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Endoscopic diagnosis of sessile serrated adenoma/polyp (SSA/P) is challenging because of their subtle appearance.
|
28687028 |
2018 |